Document is current
Any future updates will be listed below
-
Authors
Higué, Jules https://orcid.org/0009-0004-4156-3165
Orvain, Corentin https://orcid.org/0000-0002-8717-0824
Dumas, Pierre-Yves
Peterlin, Pierre
Hospital, Marie-Anne
Barrière, Sabrina
Couturier, Audrey
Carre, Martin
Chantzi, Areti
Tavernier, Emmanuelle
Delabesse, Éric
Bidet, Audrey https://orcid.org/0000-0003-0992-8377
Bouvier, Anne
Mozziconacci, Marie-Joelle
Véronèse, Lauren https://orcid.org/0000-0002-4414-7974
Pastoret, Cédric https://orcid.org/0000-0002-5675-3154
Tondeur, Sylvie
Flandrin-Gresta, Pascale https://orcid.org/0000-0001-6258-7028
Lachot, Sébastien
Cazaux, Marine
Thépot, Sylvain
Forcade, Edouard https://orcid.org/0000-0002-8873-2868
Chevallier, Patrice
Devillier, Raynier https://orcid.org/0000-0002-4045-8310
Aspas Requena, Gaspar
Bertoli, Sarah https://orcid.org/0000-0003-1084-2781
Pigneux, Arnaud https://orcid.org/0000-0001-5479-0261
Récher, Christian https://orcid.org/0000-0002-3332-4525
- License Information
-
More Information
Article History
Received: 4 May 2025
Revised: 3 July 2025
Accepted: 28 July 2025
First Online: 21 August 2025
Competing interests
: Sarah Bertoli declares a consulting or advisory role with Abbvie, Astellas, BMS-Celgene, Jazz Pharmaceuticals as well as Servier and received travel grants from Abbvie and Pfizer. Christian Récher declares a consulting or advisory role with Abbvie, Amgen, Astellas, BMS, Boehringer, Daiichi-Sankyo, Jazz Pharmaceuticals, Janssen and Servier, received research funding from Abbvie, Amgen, Astellas, BMS, Daiichi-Sankyo, Iqvia and Jazz Pharmaceuticals, and support for attending meetings and/or travel from Abbvie, Novartis and Servier. Arnaud Pigneux declares a consulting or advisory role with Astellas, BMS, Servier, Abbvie, Gilead, Jazz Pharmaceuticals, Novartis, Pfizer, received research funding from Astellas, BMS, Roche, Servier and support for attending meetings and/or travel from Servier, Abbvie. All other authors declare no competing interests.
